Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 21, 2017; 23(15): 2771-2784
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2771
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2771
Figure 10 Venn diagram of metabolites differentially expressed in urinary samples of the non-alcoholic fatty liver disease vs control, non-alcoholic steatohepatitis vs control, and non-alcoholic fatty liver disease vs non-alcoholic steatohepatitis groups.
NAFLD: Non-alcoholic fatty liver disease; NASH: Non-alcoholic steatohepatitis.
- Citation: Dong S, Zhan ZY, Cao HY, Wu C, Bian YQ, Li JY, Cheng GH, Liu P, Sun MY. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease. World J Gastroenterol 2017; 23(15): 2771-2784
- URL: https://www.wjgnet.com/1007-9327/full/v23/i15/2771.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i15.2771